You are here

Article Text

Article menu

Download PDFPDF

Cardiac risk factors and prevention
Original research article
Cardiovascular risk factors and disease among non-European immigrants living in Catalonia
  1. Miguel Cainzos-Achirica1,
  2. Emili Vela2,
  3. Montse Cleries2,
  4. Usama Bilal3,
  5. Josepa Mauri4,
  6. Maria Jesus Pueyo5,
  7. Alba Rosas5,
  8. Cristina Enjuanes1,
  9. Michael J Blaha6,
  10. Alka M Kanaya7,
  11. Josep Comin-Colet1
  1. 1 Hospital Universitari de Bellvitge, L’Hospitalet de Llobregat, Spain
  2. 2 Healthcare Information and Knowledge Unit, Catalan Health Service, Barcelona, Spain
  3. 3 Department of Epidemiology and Biostatistics, Drexel University, Philadelphia, Pennsylvania, USA
  4. 4 Interventional Cardiology, HU Germans Trias i Pujol, Badalona, Spain
  5. 5 Health Department of the Government of Catalonia, Barcelona, Spain
  6. 6 Medicine/Cardiology, Johns Hopkins Hospital, Baltimore, Maryland, USA
  7. 7 UCSF, San Francisco, California, USA
  1. Correspondence to Dr Miguel Cainzos-Achirica, Department of Cardiology, Hospital Universitari de Bellvitge, Barcelona 08907, Spain; miguel.cainzos{at}gmail.com

Abstract

Objective To describe the prevalence and incidence of cardiovascular risk factors, established cardiovascular disease (CVD) and cardiovascular medication use, among immigrant individuals of diverse national origins living in Catalonia (Spain), a region receiving large groups of immigrants from all around the world, and with universal access to healthcare.

Methods We conducted a population-based analysis including >6 million adult individuals living in Catalonia, using the local administrative healthcare databases. Immigrants were classified in 6 World Bank geographic areas: Latin America/Caribbean, North Africa/Middle East, sub-Saharan Africa, East Asia and South Asia. Prevalence calculations were set as of 31 December 2017.

Results Immigrant groups were younger than the local population; despite this, the prevalence of CVD risk factors and of established CVD was very high in some immigrant subgroups compared with local individuals. South Asians had the highest prevalence of diabetes, and of hyperlipidemia among adults aged <55 years; hypertension was highly prevalent among sub-Saharan Africans, and obesity was most common among women of African and South Asian ancestry. In this context, South Asians had the highest prevalence of coronary heart disease across all groups, and of heart failure among women. Heart failure was also highly prevalent in African women.

Conclusions The high prevalence of risk factors and established CVD among South Asians and sub-Saharan Africans stresses the need for tailored, aggressive health promotion interventions. These are likely to be beneficial in Catalonia, and in countries receiving similar migratory fluxes, as well as in their countries of origin.

  • global disease patterns
  • epidemiology
  • coronary artery disease
  • diabetes

https://doi.org/10.1136/heartjnl-2018-314436

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Introduction

    In 2018, immigration from low-income and middle-income countries has become one of the central topics in the European political agenda.1 2 Lack of significant improvements in economic conditions in countries of origin, together with the progressive population ageing in most European countries3 are likely to keep boosting this trend in the coming decades.

    One of the key challenges that countries receiving large immigrant populations face is the limited knowledge about the specific health needs of these individuals, particularly among immigrants from low-income and middle-income countries. Specifically, although cardiovascular disease (CVD) is considered the number one cause of death throughout the world,4 important differences are believed to exist across countries and racial/ethnic groups in terms of their burden of cardiovascular risk factors and established CVD. Although reports are available from some countries of origin,5–7 direct comparisons between diverse immigrant subgroups living in a common setting are currently very few, particularly from a population-level standpoint and including individuals from Asia, Africa and Latin America. Gaining a better understanding about the health characteristics and needs of these individuals may help inform tailored preventive interventions, targeted screening programmes and allocation of sufficient resources.

    In the Analisis del Sindrome coronario agudo en Inmigrantes del sur de Asia en nuestro Medio study, we demonstrated that South Asian immigrants living in Catalonia (Spain) are younger at the time of their first myocardial infarction, and have a more severe coronary atherosclerotic disease than their local counterparts.8 Taking advantage of the unique characteristics of Catalonia, a low CVD risk9 region receiving large groups of immigrants from all around the world,10 and with universal access to healthcare for all residents, in this analysis we move a step further and describe the prevalence of cardiovascular risk factors, established CVD and cardiovascular medication use, among residents of South Asian ancestry and of other Asian, African and Latin American immigrant groups.

    Methods

    Data source

    We used the database of the Catalan Health Surveillance System of the Government of Catalonia. The characteristics of this very large, exhaustive, administrative database have been reported before.11 Briefly, the database includes information on individual-level demographics, medical diagnoses and pharmacy dispensing (among other characteristics), for all residents of Catalonia. Medical diagnoses are coded using the International Classification of Diseases, 9th Edition, Clinical Modification and the Anatomical Therapeutic Chemical Classification System is used to code pharmacy dispensing. The database undergoes periodical quality control checks.

    Research ethics

    The study used de-identified, retrospective data, and the need for written informed consent was waived.12

    Study population

    For the present analysis we included all residents from Catalonia registered in the local census, 18 years of age or older as of 31 December 2017, regardless of their country of origin. Information on country of origin was available from the local census, and participants were considered ‘local’ unless an alternative nationality had been specified. For non-local (ie, immigrant) individuals, the following subgroups were defined based on the classification by the World Bank13: Latin America, Europe/Central Asia (excluding Spain), Northern Africa, sub-Saharan Africa, East Asia, South Asia and North America (figure 1 and online supplementary table S1).

    Supplemental material

    Figure 1
    Figure 1

    Study population. Individuals from Europe/Central Asia and from North America were not included in the analyses. Percentages may not sum 100% due to rounding.

    Because the focus of the present analysis was on the cardiovascular health and needs of immigrants from low-income and middle-income countries, the ‘North America’ (ie, the USA and Canada) and the ‘Europe/Central Asia’ (ie, all European countries except Spain) groups were excluded from the analyses.

    Study design and data collection

    For demographic characterisations and prevalence estimations we conducted a cross-sectional analysis, set as of 31 December 2017, and using all the cumulative historical information available (ie, recorded in the database) for each participant. For incidence estimations we used a longitudinal design, and followed participants for incident disease from 1 January 2017 to 31 December 2017. For medication use, we evaluated the number of prescriptions filled of each specific drug during the year 2017.

    We assessed the prevalence and incidence of several risk factors, including diabetes, hypertension, hyperlipidemia, obesity and tobacco use; and the prevalence and incidence of key CVD conditions including coronary heart disease (CHD), cerebrovascular disease, atrial fibrillation and heart failure (HF). We also evaluated the use of lipid-lowering drugs, antidiabetic drugs, beta-blockers, ACE inhibitors, angiotensin II antagonists, antiplatelets and anticoagulants (online supplementary tables S2 and S3).

    Statistical analyses

    We built population pyramids for each geographic group included in the analysis. Prevalence and incidence calculations were performed by area of origin, sex and 5-year age groups. Prevalence was calculated as the number of individuals with the characteristic of interest, divided by the total number of individuals alive as of 31 December 2017, expressed per 1000 people; and incidence was calculated as the number of new cases recorded between 1 January 2017 and 31 December 2017, divided by the number of individuals at risk, per 1000 individuals at risk.

    In a sensitivity analysis, all calculations were repeated excluding individuals with no recorded data on nationality in the census database (n=2 296 308), all of whom were assumed to be ‘local’ in the main analyses (when immigration was not a frequent phenomenon in Spain, nationality was not systematically recorded in some local censuses).

    All statistical analyses were performed using R software V.3.2.

    Results

    Study participants

    Of the 6 080 684 residents of Catalonia who were 18 years of age or older as of 31 December 2017, a total of 5 281 238 (86.9%) were considered ‘local’, and 799 446 (13.1%) were considered immigrants, that is, of other, non-Spanish national origin. Among the latter, the ‘Europe/Central Asia’ group was the largest (n=253 171), followed by ‘Latin America and Caribbean’ (n=217 529). On the other hand, the ‘North America’ was the smallest across all groups (figure 1).

    Demographic characteristics

    Figure 2 presents the population pyramid of each of the six groups included in the analyses. The local population was the oldest (mean age 51.5 years), having the largest proportion of individuals in the older age strata across all groups. Among immigrant groups, the youngest populations were those of South Asian and of sub-Saharan ancestries (mean age 36.5 and 37.7 years, respectively). In both, the population was predominantly male (71.4% for South Asians, 74.5% for sub-Saharan Africans). Conversely, among Latin American and East Asian immigrants women were the majority (59.2% and 54.2% women, respectively).

    Figure 2
    Figure 2

    Population pyramids of local and five immigrant group residents living in Catalonia (Spain), as of 31 December 2017.

    Cardiovascular risk factors

    Among men, the prevalence of diabetes was much higher in South Asians than in the local population or in any other immigrant group (figure 3). For example, for men aged 50–54 years, the prevalence of diabetes among South Asians was almost threefold that for local individuals of the same age (215 per 1000 compared with 76 per 1000). These differences were even more extreme among women, South Asians having the highest prevalence (almost sevenfold that for local women aged 50–54 years: 280 per 1000 compared with 41 per 1000), followed by Middle East/North Africans, and sub-Saharans. Consistent findings were observed in the analyses evaluating use of drugs for diabetes (figure 3) and incident diabetes (online supplementary figure S1).

    Figure 3
    Figure 3

    Prevalence of diabetes and of diabetes medication use, by sex, age strata and geographic origin, Catalonia (Spain), 31 December 2017.

    The prevalence of hypertension in sub-Saharan Africans and in South Asians exceeded that of local individuals, specifically among men ages <55 years, and among women of any age (figure 4 and online supplementary figure S2). For hyperlipidemia, the highest prevalence among both men and women aged <55 years was observed in South Asians, while in older individuals the local population showed the highest prevalence (figure 4 and online supplementary figure S2). Data on the use of beta-blockers, ACE inhibitors, angiotensin II antagonists and lipid-lowering therapies is presented in online supplementary figures S3 to S6. In general, differences between groups were smaller in terms of drug use than those observed for prevalence of conditions.

    Figure 4
    Figure 4

    Prevalence of hypertension and of hyperlipidemia by sex, age strata and geographic origin, Catalonia (Spain), 31 December 2017.

    The local population also had the highest prevalence of tobacco use in both men and women, and of obesity among men (figure 5 and online supplementary figure S7). Among women, obesity was highly prevalent among Africans and South Asians, their incidence during 2017 also being higher than among local women (figure 5 and online supplementary figure S7).

    Figure 5
    Figure 5

    Prevalence of obesity and of tobacco use by sex, age strata and geographic origin, Catalonia (Spain), 31 December 2017.

    Coronary heart disease and cerebrovascular disease

    Among men, the highest prevalence of CHD was observed in South Asians for all age groups within the 35–79 years age range (figure 6). For example, among individuals 65–69 years of age, the prevalence of CHD in South Asians was almost twofold that for local men, which ranked second in terms of prevalence (224 per 1000 compared with 119 per 1000). South Asian men were also the first group in terms of incidence of CHD during 2017 (online supplementary figure S8). The differences in prevalence were even more extreme among women, the prevalence of CHD in South Asian women 65–69 years of age being more than 3.5-fold that in local women of the same age (137 per 1000 compared with 38 per 1000).

    Figure 6
    Figure 6

    Prevalence of coronary heart disease and of cerebrovascular disease by sex, age strata and geographic origin, Catalonia (Spain), 31 December 2017.

    Cerebrovascular disease was also more prevalent in South Asian women than in the other groups, particularly in the 60–79 year age range (figure 6). Data on the use of antiplatelet and anticoagulant therapies are presented in online supplementary figures S9 and S10.

    Atrial fibrillation and heart failure

    The local population had the highest prevalence of atrial fibrillation, except for elderly women (figure 7). For HF, differences across groups were small among men. On the other hand, among women, South Asians had the highest prevalence of HF in almost all age groups, much higher than in the local population. The frequency of HF was also important in sub-Saharan and Middle East/North African women (figure 7). In the latter groups, the incidence of HF during 2017 was also very high (online supplementary figure S11).

    Figure 7
    Figure 7

    Prevalence of atrial fibrillation and of heart failure by sex, age strata and geographic origin, Catalonia (Spain), 31 December 2017.

    Sensitivity analyses

    The results of the sensitivity analyses excluding individuals with no recorded data on their nationality in the census database remained materially unchanged compared with the main analysis (data not shown). The distribution of risk factors and of CVD was almost identical in these individuals as compared with residents with Spanish nationality.

    Discussion

    In a population-based study of >6 million adult individuals living in Catalonia, which included immigrant men and women from multiple geographic regions and national origins, immigrants were in average younger than the local population. Despite this, the prevalence of CVD risk factors and of established CVD was very high in some immigrant subgroups. Specifically, South Asians had the highest prevalence of diabetes, and of hyperlipidemia among adults aged <55 years; hypertension was highly prevalent among sub-Saharan Africans, and obesity was most common among women of African and South Asian ancestry. In this context, South Asians had the highest prevalence of CHD across all groups, and of HF among women. HF was also highly prevalent among African women.

    Our observations for the South Asian group are consistent with those from prior reports in both the Asian subcontinent, as well as in other Western countries of destination, where South Asians consistently showed a very high prevalence of metabolic abnormalities, especially diabetes, and of premature and aggressive CHD.5 8 14–17 A number of potential underlying mechanisms have been proposed, including genetic predisposing factors, cultural and lifestyle determinants such as low levels of physical activity or diets rich in highly atherogenic fat, and metabolic factors such as abdominal adiposity, insulin resistance, high-density lipoprotein cholesterol abnormalities or high levels of Lp[a], among others.5 8 14–21

    Our findings for sub-Saharan African women are also consistent with prior reports, where obesity and hypertension have been shown to be particularly relevant as underlying risk factors for the high incidence of CHD and stroke in the black population.22 23 On the other hand, in our study sub-Saharan African men showed a healthier profile, which may be a consequence of the healthy migrant effect, which has shown to be important among male immigrant workers in Spain.24 Nonetheless, underdiagnosis of risk factors among immigrant individuals25 (eg, hypertension among sub-Saharan African men, hyperlipidemia among sub-Saharan African women) is also a possibility, and systematic detection of cardiovascular risk factors in these individuals should be pursued, similar to the local population.

    In Southern Europe, Regidor et al observed that among immigrants 20–64 years of age living in Spain, those of Eastern Europe, sub-Saharan Africa and South Asia had a higher age-adjusted cardiovascular mortality compared with the local population.26 In Italy, Fedeli et al recently observed very high rates of diabetes, dyslipidemia and CHD among South Asians, and of hypertension and cerebrovascular disease among African immigrants, particularly among women.27

    In addition, in both South Asians and sub-Saharan Africans we also identified an increased risk of HF, a finding that stresses even further the need for aggressive, early preventive interventions in these groups. Furthermore, local specific studies are needed to better characterise the key mechanisms involved, as means for maximising the effectiveness of subsequent, local health promotion interventions.

    The present study has important implications. In 2018, international migration has become a global phenomenon, with an estimated 1 billion people moving or having moved to other countries.28 In this context, our findings may be used by the health authorities of Catalonia, other Spanish regions and other countries receiving similar migratory fluxes, to inform tailored health promotion interventions and targeted screening programmes—aimed at preventing the development of metabolic risk factors, and of established CVD in immigrant individuals, particularly in those of South Asian and African ancestries. For example, targeted, culturally adapted campaigns promoting daily physical activity, weight loss and dietary interventions reducing the intake of carbohydrates and salt are likely to be very beneficial among these individuals. In some Western countries, intake of cardbohydrates has been shown to be high among first-generation adolescent South Asian immigrants.29 Therefore, these interventions may be particularly beneficial if started at early ages. Importantly, should those interventions prove effective, similar interventions could also be considered in their countries of origin, where CVD is already a major public health issue.5–7

    Our findings also have important clinical implications. Increased awareness within the medical community about the importance of specific CVD risk factors in some immigrant subgroups might result in a more personalised and improved prevention and screening. Also, increased awareness about the importance of CVD in specific subgroups (eg, the very high prevalence of CHD among South Asian individuals) may enhance diagnosis and therapy in these patients. Finally, recalibration and/or development of local, CVD risk assessment algorithms could be considered, in order to account for the higher CVD risk of these subgroups.

    Study strengths

    Our study has several strengths. Every year, Catalonia receives immigrants from a variety of national origins (including Latin America, Northern and sub-Saharan Africa and East and South Asia, among others). This allowed conducting a side-by-side comparative analysis including most of the geographic groups defined by the World Bank,13 all of them living in a same geographical area. In addition, the size of the groups included in the analyses was very large, allowing for detailed, stratified analyses by age and sex.

    Study limitations

    Some limitations must also be acknowledged. First, we used information recorded in an administrative database rather than based on direct examinations. This may have led to an underestimation of the prevalence of some risk factors and chronic conditions, at least of those typically detected/recorded in the primary care setting, among individuals not using the public primary care system often. This may have been particularly important among immigrants: in Spain, most immigrant groups use the public healthcare system less frequently than the local population; particularly men.25 This may have resulted in a conservative bias regarding the actual prevalence of risk factors and disease among immigrant individuals.

    Second, undocumented immigrants not registered in the local census would not be captured in the database, consequently, these individuals would not contribute to either the denominator or to the numerator of the prevalence/incidence estimations. Nonetheless, in Catalonia this group would be expected to be small, as registration in the local census is accessible and grants access to the public healthcare system, among other advantages.

    Third, the generalisability of our findings to other countries is unknown. Fourth, because we did not have information on length of stay in Catalonia, we could not assess the effect of acculturation. Future studies with longer follow-up and more detailed information on length of stay will allow a better characterisation of the interplay between racial/ethnic risk and a low CVD risk environment such as Catalonia.

    Fifth, although in Europe a body mass index of ≥30 kg/m2 is used to define obesity, WHO recommends a lower threshold in Asian populations.30 This means that the prevalence of obesity may have been underestimated in Asian individuals, as in most patients local physicians would be expected to have used the 30 kg/m2 threshold.

    Finally, although we used the World Bank’s classification, within-geographic group heterogeneity is possible, particularly within very large groups such as the South Asian and the sub-Saharan African. Studies using country-level information may provide further insights on country-level differences in the prevalence of cardiovascular risk factors and CVD.

    Conclusions

    In a population-based study of >6 million individuals living in Catalonia (Spain), which included immigrant individuals of multiple geographical regions exposed to similar environmental features, the prevalence of CVD risk factors and of established CVD was very high among specific immigrant groups, particularly South Asians and sub-Saharan Africans. Our findings stress the need to develop tailored, aggressive health promotion interventions, aimed at preventing the development of metabolic risk factors, particularly diabetes, hypertension and obesity, and of established CHD and HF among immigrant individuals—especially in those of South Asian and sub-Saharan ancestries. Such interventions should be considered by the health authorities of regions receiving similar migratory fluxes, as well as in the countries of origin.

    Key questions

    What is already known on this subject?

    • South Asian immigrants living in Catalonia (Spain) hospitalised for a first myocardial infarction have a more severe atherosclerotic coronary disease than their local counterparts.

    • There were no population-based studies available on the prevalence of cardiovascular disease (CVD) or of CVD risk factors in this or other immigrant groups living in Catalonia.

    What might this study add?

    • In a population-based study of >6 million individuals living in Catalonia, South Asian immigrants had the highest prevalence of diabetes, of coronary heart disease (CHD) across all groups and of heart failure (HF) among women.

    • Sub-Saharan African women had a high prevalence of hypertension, obesity and HF.

    How might this impact on clinical practice?

    • Tailored, aggressive health promotion interventions should be implemented, aimed at preventing the development of metabolic risk factors, particularly diabetes, hypertension and obesity, and of established CHD and HF among South Asian and sub-Saharan immigrants.

    • This should be considered by the health authorities of regions receiving similar migratory fluxes, as well as by those from the countries of origin.

    References

    1. ↵
      The Guardian. Aquarius migrants arrive in Spain after rough week at sea. https://www.theguardian.com/world/2018/jun/17/migrant-rescue-ship-aquarius-to-dock-in-spain-after-rough-week-at-sea (Accessed 28 Sep 2018).
    2. ↵
      European Commission. The EU and the Migration Crisis. http://publications.europa.eu/webpub/com/factsheets/migration-crisis/en/ (Accessed 28 Sep 2018).
    3. ↵
    4. ↵
      2. Benjamin EJ ,
      3. Virani SS ,
      4. Callaway CW , et al
      . Heart Disease and Stroke Statistics-2018 update: a report from the American Heart Association. Circulation 2018;137:e67–92.doi:10.1161/CIR.0000000000000558
      OpenUrlFREE Full Text
    5. ↵
      2. Goyal A ,
      3. Yusuf S
      . The burden of cardiovascular disease in the Indian subcontinent. Indian J Med Res 2006;124:235–44.
      OpenUrlPubMedWeb of Science
    6. ↵
      2. Ntsekhe M ,
      3. Damasceno A
      . Recent advances in the epidemiology, outcome, and prevention of myocardial infarction and stroke in sub-Saharan Africa. Heart 2013;99:1230–5.doi:10.1136/heartjnl-2012-303585
      OpenUrlAbstract/FREE Full Text
    7. ↵
      2. Rivera-Andrade A ,
      3. Luna MA
      . Trends and heterogeneity of cardiovascular disease and risk factors across Latin American and Caribbean countries. Prog Cardiovasc Dis 2014;57:276–85.doi:10.1016/j.pcad.2014.09.004
      OpenUrlCrossRefPubMed
    8. ↵
      2. Caínzos-Achirica M ,
      3. García-García C ,
      4. Elosua R , et al
      . Myocardial infarction in South Asian immigrants in Catalonia. Results from the ASIAM Study. Rev Esp Cardiol 2013;66:405–7.doi:10.1016/j.rec.2012.10.008
      OpenUrl
    9. ↵
      2. Piepoli MF ,
      3. Hoes AW ,
      4. Agewall S , et al
      . 2016 European Guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2016;37:2315–81.doi:10.1093/eurheartj/ehw106
      OpenUrlCrossRefPubMed
    10. ↵
    11. ↵
      2. Farré N ,
      3. Vela E ,
      4. Clèries M , et al
      . Medical resource use and expenditure in patients with chronic heart failure: a population-based analysis of 88 195 patients. Eur J Heart Fail 2016;18:1132–40.doi:10.1002/ejhf.549
      OpenUrl
    12. ↵
      World Medical Association. Declaration of Helsinki – ethical principles for medical research involving human subjects. https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/ (Accessed 28 Sep 2018).
    13. ↵
      The World Bank. Annual Report 2017. Regional Perspectives. http://www.worldbank.org/en/about/annual-report/region-perspectives (Accessed 28 Sep 2018).
    14. ↵
      European Observatory on Health Systems and Policies Series. Migration and health in the European Union. http://www.euro.who.int/__data/assets/pdf_file/0019/161560/e96458.pdf.
    15. ↵
      2. Kanaya AM ,
      3. Herrington D ,
      4. Vittinghoff E , et al
      . Understanding the high prevalence of diabetes in U.S. south Asians compared with four racial/ethnic groups: the MASALA and MESA studies. Diabetes Care 2014;37:1621–8.doi:10.2337/dc13-2656
      OpenUrlAbstract/FREE Full Text
    16. ↵
      2. Anand SS ,
      3. Yusuf S ,
      4. Vuksan V , et al
      . Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet 2000;356:279–84.doi:10.1016/S0140-6736(00)02502-2
      OpenUrlCrossRefPubMedWeb of Science
    17. ↵
      2. Joshi P ,
      3. Islam S ,
      4. Pais P , et al
      . Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. JAMA 2007;297:286–94.doi:10.1001/jama.297.3.286
      OpenUrlCrossRefPubMedWeb of Science
    18. ↵
      2. Volgman AS ,
      3. Palaniappan LS ,
      4. Aggarwal NT , et al
      . Atherosclerotic Cardiovascular Disease in South Asians in the United States: epidemiology, risk factors, and treatments: a scientific statement from the American Heart Association. Circulation 2018;138:e1–e34.doi:10.1161/CIR.0000000000000580
      OpenUrlAbstract/FREE Full Text
    19. ↵
      2. Prabhakaran D ,
      3. Singh K ,
      4. Roth GA , et al
      . Cardiovascular diseases in india compared with the United States. J Am Coll Cardiol 2018;72:79–95.doi:10.1016/j.jacc.2018.04.042
      OpenUrlFREE Full Text
    20. ↵
      2. Ahmed ST ,
      3. Rehman H ,
      4. Akeroyd JM , et al
      . Premature Coronary Heart Disease in South Asians: Burden and Determinants. Curr Atheroscler Rep 2018;20:6.doi:10.1007/s11883-018-0706-1
      OpenUrl
    21. ↵
      2. Kakde S ,
      3. Bhopal RS ,
      4. Bhardwaj S , et al
      . Urbanized South Asians' susceptibility to coronary heart disease: The high-heat food preparation hypothesis. Nutrition 2017;33:216–24.doi:10.1016/j.nut.2016.07.006
      OpenUrl
    22. ↵
      2. Steyn K ,
      3. Sliwa K ,
      4. Hawken S , et al
      . Risk factors associated with myocardial infarction in Africa: the INTERHEART Africa study. Circulation 2005;112:3554–61.doi:10.1161/CIRCULATIONAHA.105.563452
      OpenUrlAbstract/FREE Full Text
    23. ↵
      2. Opie LH ,
      3. Seedat YK
      . Hypertension in sub-Saharan African populations. Circulation 2005;112:3562–8.doi:10.1161/CIRCULATIONAHA.105.539569
      OpenUrlAbstract/FREE Full Text
    24. ↵
      2. Gimeno-Feliu LA ,
      3. Calderón-Larrañaga A ,
      4. Diaz E , et al
      . The healthy migrant effect in primary care. Gac Sanit 2015;29:15–20.doi:10.1016/j.gaceta.2014.07.007
      OpenUrl
    25. ↵
      2. Regidor E ,
      3. Sanz B ,
      4. Pascual C , et al
      . [Health services utilization by the immigrant population in Spain]. Gac Sanit 2009;23(Suppl 1):4–11.doi:10.1016/j.gaceta.2009.01.010
      OpenUrlCrossRefPubMed
    26. ↵
      2. Regidor E ,
      3. Astasio P ,
      4. Calle ME , et al
      . The association between birthplace in different regions of the world and cardiovascular mortality among residents of Spain. Eur J Epidemiol 2009;24:503–12.doi:10.1007/s10654-009-9363-6
      OpenUrlCrossRefPubMed
    27. ↵
      2. Fedeli U ,
      3. Avossa F ,
      4. Ferroni E , et al
      . Diverging patterns of cardiovascular diseases across immigrant groups in Northern Italy. Int J Cardiol 2018;254:362–7.doi:10.1016/j.ijcard.2017.12.014
      OpenUrl
    28. ↵
      2. Abubakar I ,
      3. Aldridge RW ,
      4. Devakumar D , et al
      . The UCL-Lancet Commission on Migration and Health: the health of a world on the move. Lancet 2018;392:2606–54.doi:10.1016/S0140-6736(18)32114-7
      OpenUrlCrossRefPubMed
    29. ↵
      2. Martyn-Nemeth P ,
      3. Quinn L ,
      4. Menon U , et al
      . Dietary profiles of first-generation South Asian Indian adolescents in the United States. J Immigr Minor Health 2017;19:309–17.doi:10.1007/s10903-016-0382-6
      OpenUrl
    30. ↵
      WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363:157–63.doi:10.1016/S0140-6736(03)15268-3
      OpenUrlCrossRefPubMedWeb of Science

    Footnotes

    • Contributors MC-A, EV, MC, JM and JC-C participated in the conception, design and interpretation of the data, and on the drafting of the manuscript. EV and MC also conducted the statistical analyses. UB prepared the figures, interpreted the data and participated in the the drafting of the manuscript. MJP, AR, CE and AMK participated in the interpretation of the data and revised the manuscript critically for important intellectual content.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Ethics approval This study was approved by the research ethics committee of the Bellvitge Biomedical Research Institute (IDIBELL), and complied with the Declaration of Helsinki.

    • Provenance and peer review Not commissioned; externally peer reviewed.

    • Patient consent for publication Not required.